Tissue-Specific Expression Patterns of MicroRNA during Acute Graft-versus-Host Disease in the Rat

Dasaradha Jalapothu1, Margherita Boieri2, Rachel E Crossland3

  • 1Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo , Oslo , Norway.

Frontiers in Immunology
|October 4, 2016
PubMed

Insights

This study reveals tissue-specific microRNA (miRNA) signatures in acute graft-versus-host disease (aGvHD) target organs. These findings highlight distinct molecular pathologies and potential therapeutic targets beyond peripheral blood analysis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Acute graft-versus-host disease (aGvHD) is a severe complication of allogeneic hematopoietic stem cell transplantation.
  • Donor T cells attacking host tissues cause inflammation and damage in aGvHD.
  • MicroRNAs (miRNAs) are key regulators of biological processes and disease pathology.

Purpose of the Study:

  • To identify miRNA signatures in target tissues of aGvHD to understand its molecular pathology.
  • To investigate tissue-specific miRNA expression patterns in a rat model of aGvHD.

Main Methods:

  • A rat model of aGvHD was established using MHC-mismatched bone marrow and donor T cell infusion.
  • Expression profiling of 423 rat miRNAs was performed in skin, gut, and lung tissues, and intestinal T cells using NanoString and qPCR.
  • MHC-matched transplanted rats served as controls.

Main Results:

  • Tissue-specific miRNA expression patterns were observed in aGvHD.
  • In skin, miR-34b was upregulated and miR-326 downregulated; in the gut, miR-743b was downregulated.
  • miR-146a and miR-155 were upregulated in aGvHD skin tissue; 23 miRNAs were differentially regulated in intestinal T cells.

Conclusions:

  • Comprehensive miRNA profiling reveals tissue-specific differences in aGvHD, which may be missed by peripheral blood analysis alone.
  • These tissue-specific miRNAs could contribute to distinct pathological mechanisms in aGvHD.
  • Identified miRNAs represent potential therapeutic targets for aGvHD treatment.

Related Concept Videos